希玛医疗控股有限公司（股票代码：03309）于2026年9月24日公告披露，当日于香港联合交易所场内回购普通股240,000股，占该公司回购前已发行股本约0.0199%。本次回购每股价格介乎每股港币0.78至0.80港元，总计付出约18.99万港元。回购完成后，公司已发行股本（不包括库藏股）增减后数为1,207,458,870股，库藏股数量增至24,884,000股。公司同时披露，其可根据2026年5月20日获通过的购回授权回购多达123,234,287股，而此次回购股份数目约占上市公司购回授权获通过当日已发行股本的0.0195%。
公司在公告中确认，本次股份购回均遵守香港联合交易所有限公司《主板上市规则》及相关法律法规，并符合此前向联交所呈交的说明函件所载资料。公告由公司秘书陈华平签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.